111 related articles for article (PubMed ID: 2433727)
1. Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line.
Manzin A; Bagnarelli P; Brugia M; Pauri P; Clementi M
Ric Clin Lab; 1986; 16(3):457-62. PubMed ID: 2433727
[TBL] [Abstract][Full Text] [Related]
2. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
3. Direct modulation of HBV surface antigen in a human, HBsAg-producing hepatocellular carcinoma cell line by alpha, beta, or gamma interferons.
Korba BE; Boumpas D; Mann D; Yoakum GH
J Med Virol; 1990 Aug; 31(4):272-6. PubMed ID: 2176672
[TBL] [Abstract][Full Text] [Related]
4. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
[TBL] [Abstract][Full Text] [Related]
5. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma].
Clementi M; Bagnarelli P; Frezza G; Santirocco N; Manzin A; Brugia M; Calegari L
G Ital Chemioter; 1985; 32(1):137-40. PubMed ID: 2420674
[No Abstract] [Full Text] [Related]
7. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
8. Relationship between depression of HBsAg production and DNA synthesis by interferons in human hepatoma cell line.
Hajnická V; Stancek D; Fuchsberger N; Kubes M
Acta Virol; 1990 Feb; 34(1):44-8. PubMed ID: 1975724
[TBL] [Abstract][Full Text] [Related]
9. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
10. Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.
Hajnická V; Stancek D
Acta Virol; 1987 Sep; 31(5):404-9. PubMed ID: 2891279
[TBL] [Abstract][Full Text] [Related]
11. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
[TBL] [Abstract][Full Text] [Related]
12. Effect of interferon on the production of HBsAg and induction of an antiviral state in human hepatoma cell line PLC/PRF/5.
Nakajima Y; Kuwata T; Tomita Y; Okuda K
Microbiol Immunol; 1982; 26(8):705-12. PubMed ID: 6294485
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.
Krasagakis K; Garbe C; Krüger S; Orfanos CE
J Invest Dermatol; 1991 Aug; 97(2):364-72. PubMed ID: 1712824
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus replication by interferon requires proteasome activity.
Robek MD; Wieland SF; Chisari FV
J Virol; 2002 Apr; 76(7):3570-4. PubMed ID: 11884582
[TBL] [Abstract][Full Text] [Related]
18. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
19. Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P
Arch Virol; 1983; 75(1-2):137-41. PubMed ID: 6187317
[No Abstract] [Full Text] [Related]
20. Lack of specific effect of adenine arabinoside, human interferon, and ribavirin on in vitro production of hepatitis B surface antigen.
Lemon SM; Bancroft WH
J Infect Dis; 1979 Nov; 140(5):798-801. PubMed ID: 528792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
